Results 331 to 340 of about 276,656 (346)
Some of the next articles are maybe not open access.

Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection

Nature Immunology, 2021
N. Hensel   +20 more
semanticscholar   +1 more source

Current epidemiology of HCV in Sicily: the RESIST-HCV model

Digestive and Liver Disease, 2019
Background: Real-world data to guide hepatitis C virus (HCV)- related public health initiatives and linkage to care of patients are lacking in our region. Aims: To describe the epidemiological features of a large cohort of patients with chronic HCV infection from Sicily included in a regional network aimed at DAA treatment (RESIST-HCV).
Di Marco, V   +17 more
openaire   +3 more sources

HCV Infection in Poland

Archives of Medical Research, 2000
Hepatitis C virus (HCV) infection is one of the most prevalent infectious diseases in the world. In 1997, hepatitis C became a statutorily noticeable disease in Poland. Nevertheless, to date, only a few notable studies on the prevalence of HCV infection have been carried out in Poland.
Krzysztof P. Bielawski   +3 more
openaire   +3 more sources

Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.

Gastroenterology, 2015
BACKGROUND & AIMS We performed a phase 2 clinical trial to evaluate the efficacy and safety of ledipasvir and sofosbuvir, with or without ribavirin, in patients infected with hepatitis C virus (HCV) genotype 3 or 6.
E. Gane   +6 more
semanticscholar   +1 more source

The HCV-bDNA probe method for measurement of HCV-RNA counts by HCV genotype

International Hepatology Communications, 1994
Abstract HCV-RNA counts have been determined previously by using the reverse transcription (RT)-competitive polymerase chain reaction (PCR) method. Recently, the HCV-branched DNA (HCV-bDNA) probe method, an application of hybridization technology, was developed, and it made an easy measurement of HCV-RNA counts possible.
openaire   +2 more sources

HCV-associated lymphomas.

Reviews in clinical and experimental hematology, 2003
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo   +3 more
openaire   +4 more sources

HCV and lymphomagenesis

The Lancet, 1996
M. Galli   +4 more
openaire   +4 more sources

Studying HCV Cell Entry with HCV Pseudoparticles (HCVpp)

2009
HCV infection leads in 50 to 80% of cases to chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma. Interferons and the nucleoside analog ribavirin form the basis for treatment but are not sufficiently effective and have numerous side effects.
François-Loïc Cosset, Birke Bartosch
openaire   +2 more sources

HCV and hypogammaglobulinemia

Journal of Hepatology, 1997
Lavilla P   +7 more
openaire   +3 more sources

HCV Antigen in anti-HCV positive sera of patients with HCV infection

2002
Only ways to detect HCV viremia have beendetection of HCV RNA by nucleid acid amplifying test (NAT). Nats wew sensitive butentails substantial operational complexity and are very expensive for screening. Recently it was developed a sensitive EIA for HCVAg detection during a period when it is free, not bound with antibody, because they were not yet ...
openaire   +1 more source

Home - About - Disclaimer - Privacy